Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Learn about safe ways to earn quick money that can help you maximize your earnings. Explore reliable options to enhance your income.
16,295 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
The U.S. federal debt surpassed $39 trillion for the first time, signaling a turning point for budgeting and markets....
The US dollar still dominates oil trades, but signals of strain are rising. Tensions in the Middle East and a push to...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...
Curious about reliable income from your stock holdings without chasing risky growth? This guide explains what Fidelit...
Ripple Prime gains a $200 million asset-based debt facility to push broader margin lending for institutions, signalin...
SVB Capital, the bank's roughly $10 billion venture arm, is being shopped as regulators unwind SVB assets. Buyers are...
DraftKings reports a mixed Q1 2026 while signaling growth hinges on prediction markets and regulatory clarity. A path...
Poly Truth launched its presale with a rapid $170,000 in the first 24 hours, signaling strong appetite for an AI back...
Clark Howard weighs in on helping a family member build credit without jeopardizing your own score, after a May 11, 2...
Legislation known as the Clarity Act moves through Congress, aiming to legalize real estate tokenization. If enacted,...